The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services, will host its 2023 Annual Gala on Thursday, September 28, at the Ziegfeld Ballroom in New York City. Honored at this year's gala will be LRF Scientific Advisory Board (SAB) member Kara Kelly, MD, who will recieve LRF's Distinguished Leadership Award. Genmab will be presented with the Lymphoma Research Foundation's Corporate Leadership Award for excellence in development of differentiated antibody therapeutics.
NEW YORK, Aug. 2, 2023 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services, will host its 2023 Annual Gala on Thursday, September 28, at the Ziegfeld Ballroom in New York City.
Honored at this year's gala will be LRF Scientific Advisory Board (SAB) member Kara Kelly, MD, who will recieve LRF's Distinguished Leadership Award. Kara Kelly, MD is the Waldemar J. Kaminski Endowed Chair of Pediatrics and Professor of Oncology at Roswell Park Comprehensive Cancer Center and Division Chief of Pediatric Hematology/Oncology at Oishei Children's Hospital and the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo where she also is a Professor of Pediatrics. A pediatric oncologist with expertise in the care of children and adolescents with leukemia and lymphoma, Dr. Kelly chaired the Hodgkin lymphoma committee for the Children's Oncology Group from 2011-2022.
"I am so incredibly honored to be receiving the Distinguished Leadership Award from the Lymphoma Research Foundation.' said Kara Kelly, MD. 'Over the years, LRF has truly facilitated bringing together the experts and scientists who are committed to making a difference in the lives of adolescents and young adults with lymphoma. It means so much that the organization has given me this recognition. I am eager to continue our collaborative work and research and keep improving outcomes for our patients."
"We are excited and proud to honor Dr. Kelly with the Distinguished Leadership Award. Her accomplishments in the field of lymphoma research have impacted the lives of hundreds of thousands of patients and have been instrumental in guiding the Foundation's adolescent and young adult lymphoma research initiative," said Meghan Gutierrez, Chief Executive Officer of LRF.
Genmab to receive the 2023 LRF Corporate Leadership Award
The Lymphoma Research Foundation will also honor Genmab, an international biotech company specializing in creation and development of differentiated antibody therapeutics for treatment of cancer and other serious diseases. Genmab is receiving this year's Corporate Leadership Award from LRF in recognition of being pioneers in antibody therapeutics for the treatment of cancer and supporting the Foundation's research initiatives and educational programs.
The Lymphoma Research Foundation will also honor Genmab, an international biotech company specializing in creation and development of differentiated antibody therapeutics for treatment of cancer and other serious diseases. Genmab is receiving this year's Corporate Leadership Award from LRF in recognition of being pioneers in antibody therapeutics for the treatment of cancer and supporting the Foundation's research initiatives and educational programs.
"We are honored to be recognized by the Lymphoma Research Foundation for our commitment to improving the lives of people affected by cancer," said Brad Bailey, Senior Vice President and General Manager, US at Genmab. "As a company at the forefront of advancing antibody-based science, we recognize the criticality of accelerating innovative research to address urgent needs within the lymphoma community. We are proud to support the important work of the Lymphoma Research Foundation in achieving our shared goals for patients."
The Annual Gala takes place at the end of Blood Cancer Awareness Month (September), celebrating the latest advancements made in lymphoma research, patient care and the dedicated individuals and institutions who help make this possible. This year's program includes a cocktail hour, followed by a seated dinner and awards ceremony and live auction, as well as updates on the latest LRF-funded research, programming, and patient services. LRF will also host an Emerging Philanthropists After Party following the conclusion of the program.
To learn more about the LRF Annual Gala, contact Rebecca Rausch at [email protected], or visit lymphoma.org/gala.
###
ABOUT LRF
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $77 million in lymphoma-specific research.
For additional information on LRF's research, education and services, visit lymphoma.org.
Media Contact
Nichole Musumeci, Lymphoma Research Foundation, (212) 349-2390, [email protected]
SOURCE Lymphoma Research Foundation
Share this article